Clinical Organizational Science (COS) and Kandel・Damasio: Reading Neuroscience as an Explanatory Layer, Not an Operational Tool
NQ Score
0/100
N1 Content Completeness
9
AI Summary (NQ-processed)
DroR Inc. (CEO: Makoto Yamanaka) has published a paper titled 'Clinical Organizational Science: An Integrative Framework for Structural Intervention in Complex Organizations' in the Organizational Psychology section of the international journal 'Frontiers in Psychology', with CEO Makoto Yamanaka as the lead author. This release is part of the COS explanatory series and repositions Kandel's neuroplasticity and Damasio's somatic marker hypothesis as a theoretical explanatory layer, not as neural measurement or stimulation. COS integrates complexity science, neuroscience, organizational psychology, and behavioral science to theorize interventions into organizational interaction structures.
AI Analysis
Frequently Asked Questions
- Q: What types of organizations can COS be applied to?
- A: Theoretically applicable to any organization, especially those with complex interaction structures.
- Q: Has the effectiveness of COS been validated?
- A: Currently at the theoretical proposal stage; empirical validation is a future research task.
- Q: Where is DroR Inc. located?
- A: Shibuya-ku, Tokyo.